Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Semjonow

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Plos One|September 2, 2016
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone AcetateMartin Boegemann, Katrin Schlack, Ann-Kathrin Fischer, et al.
Clinical Chemistry|March 2, 2005
Discordance analysis characteristics as a new method to compare the diagnostic accuracy of tests: example of complexed versus total prostate-specific antigenThomas Keller, Hermann Butz, Michael Lein, et al.
Urologia Internationalis|March 15, 2012
Testosterone-induced prostate growth is blocked by co- and preadministration of norethisterone enanthate in castrated cynomolgus monkeysJoachim Wistuba, Eberhard Nieschlag, Axel Semjonow, et al.
The International Journal of Biological Markers|July 28, 2009
20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials--analysis of 1098 patients in four centersCarsten Stephan, Chris Bangma, Giulio Vignati, et al.
European Urology|April 14, 2005
Expression of the endothelin axis in bladder cancer: relationship to clinicopathologic parameters and long-term survivalChristian Wülfing, Elke Eltze, Johann Yamini, et al.
BJU International|January 22, 2009
Clinical staging error in prostate cancer: localization and relevance of undetected tumour areasChristian Bolenz, Michael Gierth, Rainer Grobholz, et al.
Journal of Biomedical Informatics|December 29, 2015
Analysis of topographical distribution of prostate cancer and related pathological findings in prostatectomy specimens using cMDX document architectureOkyaz Eminaga, Axel Semjonow, Elke Eltze, et al.
Anticancer Research|February 11, 2014
Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center studyAnna M Westermann, Doris Schmidt, Stefan Holdenrieder, et al.
International Journal of Molecular Sciences|February 18, 2017
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with AbirateroneMartin Boegemann, Katrin Schlack, Stefan Thomes, et al.
BMC Cancer|March 16, 2016
Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancerPhillip Mikah, Laura-Maria Krabbe, Okyaz Eminaga, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Plos One|September 2, 2016
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone AcetateMartin Boegemann, Katrin Schlack, Ann-Kathrin Fischer, et al.
Clinical Chemistry|March 2, 2005
Discordance analysis characteristics as a new method to compare the diagnostic accuracy of tests: example of complexed versus total prostate-specific antigenThomas Keller, Hermann Butz, Michael Lein, et al.
Urologia Internationalis|March 15, 2012
Testosterone-induced prostate growth is blocked by co- and preadministration of norethisterone enanthate in castrated cynomolgus monkeysJoachim Wistuba, Eberhard Nieschlag, Axel Semjonow, et al.
The International Journal of Biological Markers|July 28, 2009
20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials--analysis of 1098 patients in four centersCarsten Stephan, Chris Bangma, Giulio Vignati, et al.
European Urology|April 14, 2005
Expression of the endothelin axis in bladder cancer: relationship to clinicopathologic parameters and long-term survivalChristian Wülfing, Elke Eltze, Johann Yamini, et al.
BJU International|January 22, 2009
Clinical staging error in prostate cancer: localization and relevance of undetected tumour areasChristian Bolenz, Michael Gierth, Rainer Grobholz, et al.
Journal of Biomedical Informatics|December 29, 2015
Analysis of topographical distribution of prostate cancer and related pathological findings in prostatectomy specimens using cMDX document architectureOkyaz Eminaga, Axel Semjonow, Elke Eltze, et al.
Anticancer Research|February 11, 2014
Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center studyAnna M Westermann, Doris Schmidt, Stefan Holdenrieder, et al.
International Journal of Molecular Sciences|February 18, 2017
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with AbirateroneMartin Boegemann, Katrin Schlack, Stefan Thomes, et al.
BMC Cancer|March 16, 2016
Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancerPhillip Mikah, Laura-Maria Krabbe, Okyaz Eminaga, et al.
Pageof 11